Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Ferber

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|July 2, 2021
Electrophysiological and ECG Effects of Perhexiline, a Mixed Cardiac Ion Channel Inhibitor, Evaluated in Nonclinical Assays and in Healthy SubjectsMark G Midei, Borje Darpo, Greg Ayers, et al.
Journal of Clinical Pharmacology|October 23, 2019
Effects of the Fluoroquinolones Moxifloxacin and Levofloxacin on the QT Subintervals: Sex Differences in Ventricular RepolarizationJӧrg Täubel, Krishna Prasad, Giuseppe Rosano, et al.
Journal of Clinical Pharmacology|January 12, 2019
The Cardiovascular Effects of a Meal: J-T<sub>peak</sub> and T<sub>peak</sub> -T<sub>end</sub> Assessment and Further Insights Into the Physiological EffectsJörg Täubel, Georg Ferber, Leen Van Langenhoven, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 14, 2018
Correction to: Scientific white paper on concentration-QTc modelingChristine Garnett, Peter L Bonate, Qianyu Dang, et al.
Cancer Chemotherapy and Pharmacology|April 1, 2018
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignanciesBoaz Mendzelevski, Georg Ferber, Filip Janku, et al.
British Journal of Clinical Pharmacology|June 2, 2021
Concentration-QT modelling of the novel DHFR inhibitor P218 in healthy male volunteersJӧrg Täubel, Ulrike Lorch, Georg Ferber, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 7, 2017
Scientific white paper on concentration-QTc modelingChristine Garnett, Peter L Bonate, Qianyu Dang, et al.
Clinical Pharmacology in Drug Development|May 4, 2021
A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay SensitivityJörg Täubel, Alessandro Mazzetti, Georg Ferber, et al.
Journal of Clinical Pharmacology|June 6, 2022
ECG Evaluation as Part of the Clinical Pharmacology Strategy in the Development of New Drugs: A Review of Current Practices and Opportunities Based on Five Case StudiesBorje Darpo, Marie Borin, Georg Ferber, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 31, 2013
The IQ-CSRC prospective clinical Phase 1 study: "Can early QT assessment using exposure response analysis replace the thorough QT study?"Borje Darpo, Nenad Sarapa, Christine Garnett, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|July 2, 2021
Electrophysiological and ECG Effects of Perhexiline, a Mixed Cardiac Ion Channel Inhibitor, Evaluated in Nonclinical Assays and in Healthy SubjectsMark G Midei, Borje Darpo, Greg Ayers, et al.
Journal of Clinical Pharmacology|October 23, 2019
Effects of the Fluoroquinolones Moxifloxacin and Levofloxacin on the QT Subintervals: Sex Differences in Ventricular RepolarizationJӧrg Täubel, Krishna Prasad, Giuseppe Rosano, et al.
Journal of Clinical Pharmacology|January 12, 2019
The Cardiovascular Effects of a Meal: J-T<sub>peak</sub> and T<sub>peak</sub> -T<sub>end</sub> Assessment and Further Insights Into the Physiological EffectsJörg Täubel, Georg Ferber, Leen Van Langenhoven, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 14, 2018
Correction to: Scientific white paper on concentration-QTc modelingChristine Garnett, Peter L Bonate, Qianyu Dang, et al.
Cancer Chemotherapy and Pharmacology|April 1, 2018
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignanciesBoaz Mendzelevski, Georg Ferber, Filip Janku, et al.
British Journal of Clinical Pharmacology|June 2, 2021
Concentration-QT modelling of the novel DHFR inhibitor P218 in healthy male volunteersJӧrg Täubel, Ulrike Lorch, Georg Ferber, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 7, 2017
Scientific white paper on concentration-QTc modelingChristine Garnett, Peter L Bonate, Qianyu Dang, et al.
Clinical Pharmacology in Drug Development|May 4, 2021
A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay SensitivityJörg Täubel, Alessandro Mazzetti, Georg Ferber, et al.
Journal of Clinical Pharmacology|June 6, 2022
ECG Evaluation as Part of the Clinical Pharmacology Strategy in the Development of New Drugs: A Review of Current Practices and Opportunities Based on Five Case StudiesBorje Darpo, Marie Borin, Georg Ferber, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 31, 2013
The IQ-CSRC prospective clinical Phase 1 study: "Can early QT assessment using exposure response analysis replace the thorough QT study?"Borje Darpo, Nenad Sarapa, Christine Garnett, et al.
Pageof 6